Article
Swinepox virus vector-based vaccines: attenuation and biosafety assessments following subcutaneous prick inoculation.
Veterinary research - 7 Feb 2018
Yuan Xiaomin, Lin Huixing, Li Bin, He Kongwang, Fan Hongjie
Abstract excerpt
Swinepox virus (SPV) has several advantages as a potential clinical vector for a live vector vaccine. In this study, to obtain a safer and more efficient SPV vector, three SPV mutants, Δ003, Δ010, and ΔTK were successfully constructed. A virus replication experiment showed that these SPV mutants had lower replication abilities compared to wtSPV in 10 different host-derived cell lines. Animal experiments with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
